MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
Provided By GlobeNewswire
Last update: Nov 26, 2024
EscharEx IND Submission by Year-End; Phase 3 Study to Begin Shortly Thereafter; KOL Event Set for January 8, 2025
FDA Approves NexoBrid for Pediatric Use
Read more at globenewswire.com
